Colabor Group Inc
TSX:GCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Colabor Group Inc
TSX:GCL
|
CA |
|
Aarey Drugs and Pharmaceuticals Ltd
NSE:AAREYDRUGS
|
IN |
|
Hi Sun Technology (China) Ltd
HKEX:818
|
HK |
|
Middlefield Banc Corp
NASDAQ:MBCN
|
US |
|
Innovent Biologics Inc
HKEX:1801
|
CN |
|
Insignia Financial Ltd
ASX:IFL
|
AU |
|
P
|
PetroVietnam Drilling & Well Service Corp
VN:PVD
|
VN |
|
Macquarie Telecom Group Ltd
ASX:MAQ
|
AU |
Balance Sheet
Balance Sheet Decomposition
Colabor Group Inc
Colabor Group Inc
Balance Sheet
Colabor Group Inc
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
9
|
2
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
2
|
0
|
0
|
|
| Total Receivables |
22
|
26
|
52
|
81
|
76
|
85
|
111
|
116
|
118
|
126
|
106
|
102
|
95
|
92
|
74
|
34
|
46
|
46
|
51
|
|
| Accounts Receivables |
22
|
25
|
44
|
64
|
60
|
1
|
2
|
93
|
93
|
103
|
85
|
81
|
76
|
77
|
58
|
26
|
32
|
35
|
0
|
|
| Other Receivables |
0
|
2
|
9
|
17
|
17
|
85
|
112
|
23
|
25
|
23
|
21
|
21
|
18
|
14
|
16
|
8
|
13
|
11
|
0
|
|
| Inventory |
23
|
24
|
48
|
73
|
72
|
70
|
77
|
85
|
80
|
93
|
87
|
83
|
79
|
78
|
68
|
35
|
39
|
45
|
50
|
|
| Other Current Assets |
0
|
1
|
1
|
2
|
10
|
1
|
3
|
3
|
2
|
3
|
3
|
3
|
5
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Total Current Assets |
45
|
51
|
101
|
156
|
158
|
156
|
190
|
205
|
200
|
222
|
196
|
188
|
178
|
179
|
144
|
81
|
88
|
93
|
107
|
|
| PP&E Net |
4
|
4
|
11
|
15
|
14
|
11
|
17
|
16
|
17
|
16
|
16
|
13
|
11
|
11
|
11
|
45
|
39
|
46
|
129
|
|
| PP&E Gross |
4
|
4
|
11
|
15
|
14
|
11
|
17
|
16
|
17
|
16
|
16
|
13
|
11
|
11
|
11
|
45
|
39
|
46
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
5
|
8
|
11
|
11
|
14
|
15
|
19
|
20
|
24
|
34
|
37
|
43
|
44
|
38
|
45
|
56
|
0
|
|
| Intangible Assets |
70
|
67
|
117
|
143
|
134
|
137
|
155
|
142
|
131
|
94
|
63
|
56
|
46
|
38
|
32
|
27
|
23
|
22
|
17
|
|
| Goodwill |
14
|
14
|
34
|
70
|
72
|
78
|
115
|
115
|
115
|
95
|
84
|
84
|
71
|
71
|
71
|
71
|
71
|
73
|
73
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
6
|
6
|
11
|
12
|
10
|
5
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
5
|
5
|
4
|
11
|
8
|
6
|
1
|
|
| Other Assets |
14
|
14
|
34
|
70
|
72
|
78
|
115
|
115
|
115
|
95
|
84
|
84
|
71
|
71
|
71
|
71
|
71
|
73
|
73
|
|
| Total Assets |
132
N/A
|
135
+2%
|
263
+95%
|
390
+48%
|
386
-1%
|
394
+2%
|
489
+24%
|
488
0%
|
468
-4%
|
430
-8%
|
363
-16%
|
345
-5%
|
311
-10%
|
304
-2%
|
261
-14%
|
234
-10%
|
229
-2%
|
241
+5%
|
330
+37%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
21
|
28
|
52
|
86
|
66
|
69
|
106
|
137
|
85
|
110
|
94
|
105
|
78
|
73
|
63
|
27
|
32
|
31
|
40
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
3
|
3
|
4
|
|
| Short-Term Debt |
6
|
3
|
10
|
8
|
24
|
11
|
10
|
6
|
7
|
9
|
4
|
8
|
7
|
0
|
5
|
0
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
4
|
1
|
1
|
1
|
39
|
0
|
0
|
0
|
6
|
2
|
1
|
1
|
1
|
3
|
59
|
11
|
15
|
13
|
|
| Other Current Liabilities |
8
|
15
|
16
|
30
|
32
|
34
|
31
|
27
|
21
|
13
|
10
|
1
|
21
|
24
|
20
|
8
|
9
|
10
|
8
|
|
| Total Current Liabilities |
44
|
50
|
78
|
124
|
123
|
153
|
147
|
171
|
113
|
138
|
109
|
114
|
106
|
98
|
92
|
98
|
55
|
60
|
64
|
|
| Long-Term Debt |
2
|
2
|
70
|
94
|
96
|
46
|
157
|
149
|
171
|
179
|
181
|
110
|
103
|
112
|
68
|
45
|
74
|
74
|
155
|
|
| Deferred Income Tax |
0
|
0
|
6
|
17
|
0
|
0
|
8
|
8
|
5
|
6
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Minority Interest |
31
|
30
|
29
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
1
|
5
|
21
|
2
|
1
|
3
|
5
|
5
|
5
|
4
|
4
|
1
|
2
|
3
|
3
|
3
|
0
|
|
| Total Liabilities |
78
N/A
|
82
+5%
|
184
+125%
|
270
+47%
|
240
-11%
|
200
-17%
|
313
+56%
|
331
+6%
|
294
-11%
|
329
+12%
|
295
-10%
|
228
-23%
|
214
-6%
|
211
-1%
|
161
-24%
|
145
-10%
|
132
-9%
|
138
+5%
|
221
+60%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
54
|
54
|
89
|
135
|
143
|
178
|
180
|
180
|
209
|
210
|
210
|
258
|
258
|
256
|
256
|
256
|
257
|
257
|
257
|
|
| Retained Earnings |
0
|
1
|
12
|
17
|
2
|
12
|
7
|
24
|
37
|
112
|
146
|
146
|
165
|
169
|
162
|
174
|
166
|
161
|
154
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
6
|
7
|
7
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
1
|
0
|
|
| Total Equity |
55
N/A
|
53
-3%
|
79
+49%
|
120
+52%
|
146
+22%
|
194
+33%
|
176
-9%
|
157
-11%
|
174
+10%
|
101
-42%
|
67
-33%
|
117
+73%
|
98
-16%
|
92
-5%
|
100
+8%
|
89
-11%
|
98
+10%
|
103
+5%
|
110
+7%
|
|
| Total Liabilities & Equity |
132
N/A
|
135
+2%
|
263
+95%
|
390
+48%
|
386
-1%
|
394
+2%
|
489
+24%
|
488
0%
|
468
-4%
|
430
-8%
|
363
-16%
|
345
-5%
|
311
-10%
|
304
-2%
|
261
-14%
|
234
-10%
|
229
-2%
|
241
+5%
|
330
+37%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
11
|
11
|
15
|
20
|
20
|
23
|
23
|
23
|
27
|
28
|
28
|
102
|
102
|
101
|
102
|
102
|
102
|
102
|
102
|
|